| Literature DB >> 30104466 |
Ricardo A Murcia1, Sandra M Leal2,3, Martha V Roa4,5, Edgar Nagles6, Alvaro Muñoz-Castro7, John J Hurtado8.
Abstract
In this work, six complexes (2⁻7) of Cr(III) andEntities:
Keywords: antibacterial activity; antifungal activity; cobalt(II) and chromium(III) complexes; triazole ligands
Mesh:
Substances:
Year: 2018 PMID: 30104466 PMCID: PMC6222626 DOI: 10.3390/molecules23082013
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Synthesis of the ligand (1).
Figure 1Possible structures of the complexes under study.
Electrical conductivity for 2–7 and starting salts.
| Compound | Conductivity (Ω−1 cm2 mol−1) | Type of Electrolyte (In Solution) |
|---|---|---|
| CoCl2·6H2O | 48.0 | 2:1 |
|
| 52.9 | 2:1 |
|
| 50.5 | 2:1 |
|
| 43.3 | No electrolyte |
| CrCl3·6H2O | 40.2 | 1:1 |
|
| 24.4 | No electrolyte |
|
| 30.3 | 1:1 |
|
| 27.4 | No electrolyte |
Figure 2Atom numbering for signal assignment for 1,2,4-triazole.
Some bands for the starting salts, ligands and complexes 2–7 observed in their UV/Vis spectra.
| Transition (nm) (ε(M−1 cm−1)) | ||||
|---|---|---|---|---|
| UV |
| |||
| Compound |
|
|
|
|
|
| 263(266) | |||
|
| 262(784) | 615(66) | 678(116) | |
|
| 260(3672) | |||
|
| 264(4423) | |||
|
| 264(3317) | 615(41) | 677(79) | |
|
| 263(7081) | |||
|
| 267(297) | 276(236) | ||
|
| 268(556) | 276(478) | 615(7) | 675(26) |
|
| 259(2141) | |||
| CoCl2·6H2O | 238(73) | 266(64) | 614(41) | 678(81) |
| CrCl3·6H2O | 260(2764) | |||
Antimicrobial and cytotoxic activities of ligands and complexes (MIC, CC50; μg mL−1).
| Compound | |||||||
|---|---|---|---|---|---|---|---|
|
| >2000 | 1000 | >2000 | >2000 | >2000 | >2000 | >300 |
|
| >2000 | 1000 | >2000 | >2000 | >2000 | >2000 | >300 |
|
| >2000 | 2000 | >2000 | >2000 | >2000 | >2000 | >300 |
|
| 1000–2000 | 1000 | >2000 | 125 | 125 | 500 | 277.07 ± 1.86 |
|
| 250–500 | 1000 | 1000 | 31.25 | 125 | 125 | 68.76 ± 0.97 |
|
| 250–500 | 1000 | 2000 | 62.50 | 125 | 125 | 193.63 ± 6.51 |
|
| >2000 | 1000 | 2000 | 7.81 | 62.5 | 125 | >300 |
|
| >2000 | >2000 | >2000 | 7.81 | 62.5 | 62.5 | >300 |
|
| >2000 | >2000 | >2000 | 15.62 | 31.25 | 125 | 130.60 ± 3.57 |
| Ampicillin | 0.078–0.156 | ||||||
| Gentamicin | 2.50 | 0.625 | |||||
| Amphotericin B | 0.065 | 0.31 | 0.23 | ||||
| Itraconazole | 2.0 | 0.78 | 500 | 25.22 ± 3.51 |
The results are expressed in μg mL−1 and are the average of three independent experiments.
Figure 3Optimized geometries for complexes 2–7.
Figure 4Molecular electrostatic potential maps of the studied complexes denoting their permanent dipole moments in Debye (D). Blue regions indicate charge depletion, and red regions indicate charge accumulation.
Figure 5Atom numbering for signal assignment of the NMR for 1.